Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Clinical trial NCT02460224 · COMPLETED
Trial details
- NCT number
- NCT02460224
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-17
- Primary completion
- 2020-12-31
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.